151 related articles for article (PubMed ID: 17574296)
1. Palliative chemotherapy for pulmonary pleomorphic carcinoma.
Bae HM; Min HS; Lee SH; Kim DW; Chung DH; Lee JS; Kim YW; Heo DS
Lung Cancer; 2007 Oct; 58(1):112-5. PubMed ID: 17574296
[TBL] [Abstract][Full Text] [Related]
2. Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.
Lee KW; Kim YJ; Kim JH; Bang SM; Chung JH; Lee JS
Jpn J Clin Oncol; 2011 Mar; 41(3):430-3. PubMed ID: 20926411
[TBL] [Abstract][Full Text] [Related]
3. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
5. Lymphoepithelioma-like carcinoma of the lung: experience with ten cases.
Ho JC; Lam WK; Wong MP; Wong MK; Ooi GC; Ip MS; Chan-Yeung M; Tsang KW
Int J Tuberc Lung Dis; 2004 Jul; 8(7):890-5. PubMed ID: 15260282
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.
Peschel C; Hartmann JT; Schmittel A; Bokemeyer C; Schneller F; Keilholz U; Buchheidt D; Millan S; Izquierdo MA; Hofheinz RD
Lung Cancer; 2008 Jun; 60(3):374-80. PubMed ID: 18054408
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
[TBL] [Abstract][Full Text] [Related]
10. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
[TBL] [Abstract][Full Text] [Related]
12. Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy.
d'Amato TA; Pettiford BL; Schuchert MJ; Parker R; Ricketts WA; Luketich JD; Landreneau RJ
Ann Surg Oncol; 2009 Oct; 16(10):2848-55. PubMed ID: 19609620
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer.
Park S; Ahn MJ; Ahn JS; Lee J; Hong YS; Park BB; Lee SC; Hwang IG; Park JO; Lim H; Kang WK; Park K
Lung Cancer; 2007 Oct; 58(1):116-22. PubMed ID: 17624473
[TBL] [Abstract][Full Text] [Related]
14. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of combination chemotherapy with mitomycin and vinorelbine for the treatment of advanced non-small cell lung cancer.
Wibmer T; Kropf C; Merk T; Schumann C; Hombach V; Krüger S
Lung Cancer; 2008 May; 60(2):231-9. PubMed ID: 18006111
[TBL] [Abstract][Full Text] [Related]
16. The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma.
Hong JY; Choi MK; Uhm JE; Park MJ; Lee J; Park YH; Ahn JS; Park K; Han JH; Ahn MJ
Med Oncol; 2009; 26(3):287-91. PubMed ID: 18989796
[TBL] [Abstract][Full Text] [Related]
17. [Pleomorphic lung cancer; a clinicopathologic study].
Kakegawa S; Kawashima O; Sugano M; Nagashima T; Morishita Y
Kyobu Geka; 2006 Feb; 59(2):110-3. PubMed ID: 16482903
[TBL] [Abstract][Full Text] [Related]
18. [Criteria of choice for first-line chemotherapy for Stage IV disease].
Fournel P
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S8-4S12. PubMed ID: 15687986
[No Abstract] [Full Text] [Related]
19. Second-line for small cell lung cancer: how-to-do-it?
Postmus PE
Lung Cancer; 2005 May; 48(2):263-5. PubMed ID: 15829327
[No Abstract] [Full Text] [Related]
20. Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma.
Tamura Y; Fujiwara Y; Yamamoto N; Nokihara H; Horinouchi H; Kanda S; Goto Y; Kubo E; Kitahara S; Tsuruoka K; Tsuta K; Ohe Y
BMC Res Notes; 2015 Dec; 8():800. PubMed ID: 26682906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
